MIST — Milestone Pharmaceuticals Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1408443 ·
Last close
$1.04
Market Cap
$129.48M
52W High
$1.47
52W Low
$1.01
ADV30
1,521,146
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 238,000 | 224,000 | -23,663,000 | -26,066,000 | 193,734,000 | 71,317,000 | 157,685,000 |
| Dec 2025 | 1,546,000 | — | -17,257,000 | -17,409,000 | 113,561,000 | 73,046,000 | 71,792,000 |
| Sep 2025 | 0 | — | -11,829,000 | -11,922,000 | 87,750,000 | 46,685,000 | 67,249,000 |
| Jun 2025 | 0 | — | -12,531,000 | -12,966,000 | 47,417,000 | 42,499,000 | 65,162,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-51,142,000
Investing CF
$-102,367,000
Financing CF
$179,741,000
CapEx
$-341,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.83
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-456,669,000
Inventory
$1,826,000
Receivables
$5,001,000
ST Investments
$112,899,000
EBIT TTM
$-61,325,000
Pretax Income TTM
$-68,363,000
Interest Exp TTM
$7,038,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,343,000
EBITDA
$-78,207,000
Free Cash Flow
$-41,687,376
Enterprise Value
$117,770,344
Total Cash
$170,608,992
Total Debt
$141,832,000
Shares Out
124,497,980
Trailing EPS
$-0.65
Book Value
$0.27
ROE
-35522.6%
ROA
-42.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,546,000 | -62,140,000 | -63,058,000 | 113,561,000 | 71,792,000 | — | -49,041,000 |
| Dec 2024 | 0 | -42,102,000 | -41,519,000 | 75,499,000 | 62,352,000 | — | -28,848,000 |
| Dec 2023 | 1,000,000 | -61,098,000 | -59,685,000 | 75,226,000 | 58,455,000 | — | -46,424,000 |
| Dec 2022 | 5,000,000 | -59,642,000 | -58,388,000 | 74,483,000 | 8,135,000 | — | -52,469,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.77
Max Pain — expiry 2026-09-18
max pain strike: $1.50 · spot: $1.04 · call oi: 10,642 · put oi: 706
Expected Move to 2026-09-18:
±$0.22
(21.15%) —
implied range
$0.82 –
$1.26
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INO | INOVIO PHARMACEUTICALS, INC. | $129.25M | $1.25 | — |
| PMN | ProMIS Neurosciences Inc. | $132.72M | $14.80 | — |
| VTVT | vTv Therapeutics Inc. | $134.00M | $33.89 | — |
| ADCT | ADC Therapeutics SA | $123.21M | $0.97 | — |
| ANIX | Anixa Biosciences Inc | $123.16M | $3.62 | — |
News headlines (Yahoo Finance, 1h cache)
Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial
2026-08-21 13:28 · Yahoo
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
2026-08-21 12:00 · Yahoo
Milestone Pharmaceuticals Q2 Earnings Call Highlights
2026-08-12 15:04 · Yahoo
Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates
2026-08-12 12:25 · Yahoo
Milestone Pharmaceuticals shares tumble after Q2 earnings miss
2026-08-12 12:04 · Yahoo
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST)
2026-07-29 13:35 · Yahoo
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-03 01:30 · Yahoo
Milestone (MIST) Q1 2026 Earnings Transcript
2026-06-01 14:31 · Yahoo
Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability
2026-05-15 10:49 · Yahoo
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
2026-05-14 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.